Conversion Details
Fundviser Capital (India) Limited has completed the conversion of 19,85,000 convertible warrants into equity shares, marking a significant step in bolstering its financial standing. The transaction, approved by the Board of Directors on March 23, 2026, involved each warrant being converted into one equity share of face value ₹10. This conversion occurred at a premium of ₹112.50 per share, setting the total issue price at ₹122.50 per share.
Funding and Commitment
The conversion has injected ₹18.24 crore into the company, with funds received from the promoter/promoter group and strategic investors. This capital infusion enhances Fundviser Capital's financial resources, potentially supporting its investment and financing activities. It also underscores the commitment of those investors who participated in the initial warrant allotment, strengthening the company's balance sheet.
Historical Context
These warrants originated from a preferential allotment on November 25, 2025, where 64,85,000 convertible warrants were issued at ₹122.50 each. The initial allotment required a 25% upfront payment of the issue price, with the remaining 75% due upon conversion. Fundviser Capital has a history of utilizing warrants for fundraising, notably after its transformation from a dye manufacturer to an investment and finance entity. A prior allotment of 10,00,000 warrants was approved in March 2024.
Impact on Shareholders and Risks
The issuance of new equity shares will result in a potential dilution for existing shareholders. While this event strengthens the company's capital base, the impact of this dilution on existing ownership stakes is a key consideration. Investors will also note that Fundviser Capital previously reported a net loss in the June 2024 quarter. The effective utilization of the newly raised capital will be crucial for the company's future performance.
Looking Ahead
Investors will closely monitor how Fundviser Capital deploys the ₹18.24 crore raised and its impact on the company's profitability. Future financial reports will reveal the effect of the increased equity base on key metrics like earnings per share (EPS) and other financial ratios. Any subsequent capital-raising efforts or strategic investments by Fundviser Capital will also be important for investors to track.
